Trial Profile
PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Nov 2022
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms PROTEST
- 16 Nov 2022 Planned End Date changed from 1 Dec 2023 to 1 Dec 2027.
- 16 Nov 2022 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2026.
- 15 Feb 2019 Planned number of patients changed from 1500 to 1100.